Patents by Inventor Torsten Dunkern

Torsten Dunkern has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel use for PDE5 inhibitors
    Publication number: 20100179152
    Abstract: The present invention is concerned with the use of PDE5 inhibitors in medicine.
    Type: Application
    Filed: January 4, 2010
    Publication date: July 15, 2010
    Applicant: NYCOMED GmbH
    Inventors: Torsten Dunkern, Christian Schudt, Friedrich Grimminger, Hossein Ardeschir Ghofrani, Manfred Kaps, Bernhard Rosengarten
  • 6-BENZYL-2,3,4,7-TETRAHYDRO-INDOLO [2,3-C] QUINOLINE COMPOUNDS USEFUL AS PDE5 INHIBITORS
    Publication number: 20100120730
    Abstract: The compounds of formula (I) wherein R1 to R8 and R11 have the meanings as given in the description, the salts thereof, the N-oxides of the compounds and the salts thereof, and the stereoisomers of the compounds, the salts, the N-oxides of the compounds and the N-oxides of the salts thereof are effective inhibitors of the type 5 phosphodiesterase.
    Type: Application
    Filed: January 30, 2008
    Publication date: May 13, 2010
    Applicant: NYCOMED GmbH
    Inventors: Steffen Weinbrenner, Torsten Dunkern, Degenhard Marx, Beate Schmidt, Thomas Stengel, Dieter Flockerzi, Ulrich Kautz, Daniela Hauser, Jörg Diefenbach, Johannes A.M. Christiaans, Wiro M.P.B. Menge
  • Use for PDE5 inhibitors
    Patent number: 7666872
    Abstract: The present invention is concerned with the use of PDE5 inhibitors in medicine.
    Type: Grant
    Filed: March 3, 2005
    Date of Patent: February 23, 2010
    Assignee: NYCOMED GmbH
    Inventors: Torsten Dunkern, Christian Schudt, Friedrich Grimminger, Hossein Ardeschir Ghofrani, Manfred Kaps, Bernhard Rosengarten
  • Use of Pde1c and Inhibitors Thereof
    Publication number: 20090030065
    Abstract: The present invention relates to the use of PDE1C as a novel target for the identification of compounds, which can be used for the treatment of pulmonary hypertension, fibrotic lung diseases or other fibrotic diseases outside the lung. The present invention further relates to the use of PDE1C inhibitors in the manufacture of pharmaceutical compositions for use in the therapy of those diseases.
    Type: Application
    Filed: June 13, 2006
    Publication date: January 29, 2009
    Applicant: NYCOMED GmbH
    Inventors: Torsten Dunkern, Armin Hatzelmann, Friedrich Grimminger, Ralph Schermuly
  • Novel use for pde5 inhibitors
    Publication number: 20070185114
    Abstract: The present invention is concerned with the use of PDE5 inhibitors in medicine.
    Type: Application
    Filed: March 3, 2005
    Publication date: August 9, 2007
    Applicant: ALTANA PHARMA AG
    Inventors: Torsten Dunkern, Christian Schudt, Friedrich Grimminger, Hossein Ghofrani, Manfred Kaps, Bernhard Rosengarten
  • Composition comprising a pde4 inhibitor and a pde5 inhibitor
    Publication number: 20060094723
    Abstract: The invention relates to the combined administration of a PDE4 inhibitor and a PDE5 inhibitor for the treatment of a disease in which phosphodiesterase 4 (PDE4) and/or phosphodiesterase 5 (PDE5) is detrimental.
    Type: Application
    Filed: May 19, 2004
    Publication date: May 4, 2006
    Inventors: Torsten Dunkern, Armin Hatzelmann, Christian Schudt